Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, today announced that it has
HC Wainwright & Co. analyst Joseph Pantginis initiates coverage on Tenaya Therapeutics (NASDAQ:TNYA) with a Buy rating and announces Price Target of $25.
Gainers
GeoVax Labs, Inc. (NASDAQ: GOVX) shares surged 90.2% to settle at $1.39 on Friday. GeoVax Labs, last month, said its Q1 sales results were lower year over year.